Sign in
4

Changes in Ownership

NewAmsterdam Pharma Co N.V. Filed Acc 0000950170-25-002996

Chief Business Officer acquired 14,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Audet Juliette Berangere Chief Business Officer 2025-01-07 Grant or award +14,000 15,104 D: show line 1 in the form
Loading xslF345X05/ownership.xml…